RESUMO
BACKGROUND: The influence of 5-HTT, BMPR2, EDN1, ENG, KCNA5 genes polymorphisms on susceptibility of pulmonary arterial hypertension remains uncertain. This meta-analysis is conducted for further study. METHODS: We conducted a literature search on PubMed and ISI web of science databases for searching relevant articles until November 2017. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. A total of 17 articles with 2631 PAH subjects and 5139 controls were included in the final meta-analysis. Statistical software Stata13.0 was used for data-analysis. RESULTS: A significant relationship was found between the 5-HTT L/S polymorphism and PAH in all the genetic models [LL vs. SS: ORâ¯=â¯1.60, 95% CI, 1.11-2.32; LS vs. SS: ORâ¯=â¯1.55, 95% CI, 1.10-2.21; (LSâ¯+â¯LL) vs. SS: ORâ¯=â¯1.56, 95% CI, 1.13-2.17; L vs. S: ORâ¯=â¯1.32, 95% CI, 1.08-1.62]. There were also associations of the SERT L/S polymorphism with IPAH and PAH in COPD [IPAH L/S: ORâ¯=â¯1.26, 95% CI, 1.01-1.57; PAH in COPD L/S: ORâ¯=â¯1.42, 95% CI, 1.04-1.94]. In addition, the results showed a statistically significant association between EDN1 rs5370 polymorphism and the risk of PAH in all the genetic models [TT vs. GG: ORâ¯=â¯3.32, 95% CI, 1.30-8.51; TG vs. GG: ORâ¯=â¯2.68, 95% CI, 1.54-4.66; (TGâ¯+â¯TT) vs. GG: ORâ¯=â¯2.82, 95% CI, 1.69-4.71; T vs. G: ORâ¯=â¯2.43, 95% CI, 1.60-3.68]. However, the significant association was not found between BMPR2 rs1061157, KCNA5 rs10744676, ENG rs3739817 polymorphisms and the risk of PAH (all pâ¯>â¯0.05). CONCLUSIONS: 5-HTT L/S polymorphism and END1 rs5370 polymorphism were correlated with significantly increased risk of PAH. Moreover, L allele in 5-HTT gene increased susceptibility to IPAH and PAH in COPD.
